Lantern Pharma is trading 5.4% lower at $0.57 after closing November 3, 2026, at $0.60; no company-specific explanation for the decline was identified. - The company’s published news listings show no November 3 release. - The decline follows several down sessions, but supplied market data is mixed and does not establish a broader-market cause; the reason for the after-hours decline remains unclear.